Zenotech Laboratories, Hyderabad based generic biopharmaceutical company, is planning to set up a plasma fractional facility at an investment of US$ 20-25 million. The facility will be engaged in
disaggregating the various proteins in plasma.
The global market size for plasma ingredients is estimated at US$ 20 billion, of which the main proteins including immunoglobulins have a market size of US$ 2 billion. Sources said that the possible locations for the facility are Vizag and Vijayawada. The company already has three
facilities in Hyderabad. The proposed facility would be in compliance with the US/EU regulatory standards.
|
